BiPS design rendering; an investigational prostate-stent concept.
THE CLINICAL NEED
The problem behind the design.
Men with lower urinary tract symptoms need treatment matched to the cause, prostate characteristics, symptoms and personal priorities. A new stent must be evaluated against these real clinical needs.
THE GOMIDA APPROACH
The design approach
BiPS explores temporary support through a biodegradable prostate stent, with the aim of avoiding a separate removal procedure. Gomida describes material development and clinical-evaluation planning, including material work with IIT Roorkee.
Temporary support
A concept intended to maintain urine flow through the prostatic urethra.
Biodegradable material
Research into a device designed to break down after its useful support period.
Evaluation pathway
Material behaviour, safety and patient outcomes need to be established before clinical adoption.
EVIDENCE & CURRENT STATUS
A research programme, not an established treatment.
Public material does not establish completed clinical trials, an approved indication or commercial availability for BiPS. Benefits such as avoiding removal remain design aims, not guaranteed outcomes.
The 2024 IIT Roorkee–UnivLabs announcement concerns a biodegradable ureteral stent. A ureteral stent and a prostate stent occupy different anatomical sites; that announcement is not clinical evidence for BiPS.
Start with intended use, the exact configuration and evidence relevant to your setting.
How long does the material retain useful support, and how consistently does it degrade?
What testing addresses migration, encrustation, inflammation and degradation products?
Which patients, endpoints and comparator are appropriate for clinical evaluation?
A FEW CLEAR ANSWERS
Frequently asked questions
Is BiPS the same as a ureteral stent?+
No. A ureteral stent supports drainage from the kidney to the bladder. BiPS is a prostate-stent concept addressing a different location and clinical problem.
Can it replace established BPH treatments?+
That has not been demonstrated. Treatment selection requires clinical assessment; this development concept must not be presented as a universal replacement for medication or procedures.
Will it always avoid a removal procedure?+
Avoiding a separate removal procedure is a design aim. Degradation behaviour, safety and the possibility of further intervention need clinical evaluation.
Reviewed 8 November 2026. Product images and company descriptions: Gomida. Clinical guidelines provide context, not endorsement of a Gomida device. This page is educational and does not replace professional assessment, current device instructions or local protocols.
UNIVLABS